7月9日，国药控股盘中下跌3.38%，报16.6港元，成交额8408.91万港元。
消息面上，近期多家国际机构持续减持公司股份形成抛压。摩根大通于6月30日减持87.41万股，每股作价16.0054港元，持股比例降至5.97%；贝莱德于6月22日减持751.79万股，持股比例由10.19%降至9.63%。与此同时，南向资金近20个交易日累计净减持1463.96万股，机构资金流出信号明显。此外，公司一季度营收同比下降0.63%，归母净利润同比减少2.95%，基本面承压背景下机构集中减仓进一步加剧市场悲观情绪。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.